experspadmin

Monitoring Patients With Advanced Prostate Cancer: How Frequently Should Scans and Biomarkers Be Obtained?
Oncology

Monitoring Patients With Advanced Prostate Cancer: How Frequently Should Scans and Biomarkers Be Obtained?

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Newer PET/CT Imaging Techniques Promise to Improve Detection of Metastatic Prostate Cancer
Oncology

Newer PET/CT Imaging Techniques Promise to Improve Detection of Metastatic Prostate Cancer

patient care perspectives
By Neal D. Shore, MD, FACS; Peter R. Carroll, MD, MPH
Identifying the High-Risk Patient: Prognostic Markers in Advanced Prostate Cancer
Oncology

Identifying the High-Risk Patient: Prognostic Markers in Advanced Prostate Cancer

expert roundtables
By Daniel J. George, MD; Glen Gejerman, MD; Oliver Sartor, MD; William K. Oh, MD
Stereotactic Body Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer
Oncology

Stereotactic Body Radiotherapy (SBRT) in Patients With Locally Advanced Pancreatic Cancer

patient care perspectives
By Alok Khorana, MD
Modifying Treatment Regimens to Attenuate Toxicity in Metastatic Pancreatic Cancer
Oncology

Modifying Treatment Regimens to Attenuate Toxicity in Metastatic Pancreatic Cancer

clinical topic updates
By Philip A. Philip, MD, PhD, FRCP
Load More